Managing Clinical and Translational Research During COVID-19-Managing Clinical and Translational Care During COVID-19

Managing Clinical and Translational Care During COVID-19

Video Transcription

Video Summary

This webinar discussed the impact of the COVID-19 pandemic on clinical and translational research in the context of cancer care. The panel addressed the challenges faced by healthcare professionals, researchers, and patients and shared strategies to overcome them. Telemedicine was highlighted as a valuable tool for remote patient care and access to clinical trials, enabling virtual visits, remote monitoring, and e-consent. Patient and staff safety were prioritized, and flexibility in trial protocols and remote data collection were emphasized. The concerns regarding COVID-19 vaccination for patients in clinical trials were also discussed, emphasizing the need for risk-benefit discussions and collaboration between clinicians, researchers, and advocacy groups. The panel ultimately showcased the resilience and adaptability of the healthcare and research community in navigating clinical and translational research during the pandemic.

Keywords

COVID-19 pandemic

clinical and translational research

cancer care

healthcare professionals

researchers

patients

strategies

telemedicine

remote patient care

clinical trials

patient and staff safety

trial protocols